Allugastrin

Country of origin: Poland, Polfa Poland
Pharm-Group: Astringents, coatings and antacids based on aluminum

Manufacturers: Lodz Pharmaceutical Plant Polfa (Poland), Polfa (Poland)
International name: Carbaldrat
Synonyms: Compensation
Dosage forms: suspension, lozenges, lozenges 355 mg, suspension 17g

Composition: Active ingredient - carbaldrate.

Indications for use: Esophagitis, gastritis, duodenitis, gastric ulcer, duodenal ulcer.

Contraindications: Restrictions on use. Severe renal dysfunction.

Side effects: Nausea, vomiting, increased bowel movements, constipation (rare).

Interaction: Reduces the absorption of tetracyclines (the interval between doses should be at least 2 hours)

Overdose: No data available.

Special instructions: To avoid the development of neurotoxic phenomena, carbaldrate should not be prescribed for a long time in large doses.

Literature: Encyclopedia of Medicines 2004